Literature DB >> 1601023

Acute experimental hemorrhagic-necrotizing pancreatitis induced by feeding a choline-deficient, ethionine-supplemented diet. Methodology and standards.

C Niederau1, R Lüthen, M C Niederau, J H Grendell, L D Ferrell.   

Abstract

The present work evaluates the methodology and standards of acute hemorrhagic-necrotizing pancreatitis induced by feeding a choline-deficient, ethionine-supplemented (CDE) diet to mice. The diet model appears to be a good approximation of severe necrotizing human pancreatitis. Both the gross and histological appearance of the pancreatic and peripancreatic inflammation as well as the clinical and biochemical course of diet-induced pancreatitis resemble human disease. By limiting the period of feeding the diet, one can control the mortality at any desired level between 0 and 100%. Ascites, acidosis, hypoxia and hypovolemia occur in this model as well as in human pancreatitis. The time course of the morphological and biochemical alterations have extensively been studied and are, thus, well defined in this model. Despite the differences in pathogenesis of pancreatitis induced in this model versus human disease, the experimental pancreatitis and clinical pancreatitis share several pathophysiologic features. Therefore, the model is suitable to study pathophysiologic aspects of this disease. The diet model is particularly well suitable to study the potential for new therapeutic substances. The small size of the animals used, however, is a limitation for the evaluation of surgical procedures and of new diagnostic tools. Several pitfalls and problems have to be considered in order to obtain valuable data. The amount of injury produced by the CDE diet depends critically on sex, age and weight of the mice. Special care has to be taken to guarantee that the intake of the CDE diet is identical between different experimental groups. Therefore, each set of experiments needs to include a separate control group of mice which receive the CDE diet without any other special treatment. The potential benefit of an experimental therapy can be assessed by measuring survival, various biochemical and histological features, and alterations in hematocrit, pH and blood gases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601023     DOI: 10.1159/000129238

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  15 in total

Review 1.  Animal models of gastrointestinal and liver diseases. Animal models of acute and chronic pancreatitis.

Authors:  Xianbao Zhan; Fan Wang; Yan Bi; Baoan Ji
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-14       Impact factor: 4.052

2.  Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury.

Authors:  A H Lundberg; D N Granger; J Russell; O Sabek; J Henry; L Gaber; M Kotb; A O Gaber
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

Review 3.  Antioxidative phytoceuticals to ameliorate pancreatitis in animal models: an answer from nature.

Authors:  Jong-Min Park; Sooyeon Lee; Mi Kyung Chung; Sung-Hun Kwon; Eun-Hee Kim; Kwang Hyun Ko; Chang Il Kwon; Ki Baik Hahm
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

4.  Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis.

Authors:  A H Lundberg; K Fukatsu; L Gaber; S Callicutt; M Kotb; H Wilcox; K Kudsk; A O Gaber
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

5.  Temporal correlation of tumor necrosis factor-alpha release, upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis.

Authors:  A H Lundberg; N Granger; J Russell; S Callicutt; L W Gaber; M Kotb; O Sabek; A O Gaber
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

6.  Hepatic Kupffer cell blockade reduces mortality of acute hemorrhagic pancreatitis in mice.

Authors:  B Gloor; K E Todd; J S Lane; M P Lewis; H A Reber
Journal:  J Gastrointest Surg       Date:  1998 Sep-Oct       Impact factor: 3.452

7.  Review of experimental animal models of acute pancreatitis.

Authors:  Kim Hue Su; Christine Cuthbertson; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

8.  Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.

Authors:  R Mota; F Sánchez-Bueno; J J Berenguer-Pina; D Hernández-Espinosa; P Parrilla; J Yélamos
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

9.  Effects of C1-esterase inhibitor in three models of acute pancreatitis.

Authors:  C Niederau; R Brinsa; M Niederau; R Lüthen; G Strohmeyer; L D Ferrell
Journal:  Int J Pancreatol       Date:  1995-04

Review 10.  Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research.

Authors:  Lu Wang; Ting Xu; Ruifeng Wang; Xiaobing Wang; Dong Wu
Journal:  Dig Dis Sci       Date:  2021-05-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.